China Medical System Holdings Limited (OTCMKTS:CHSYF) Short Interest Down 65.2% in March

China Medical System Holdings Limited (OTCMKTS:CHSYF) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 146,900 shares, a decline of 65.2% from the March 15th total of 422,000 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

China Medical System Stock Performance

CHSYF remained flat at $0.93 during trading on Thursday. China Medical System has a 52 week low of $0.93 and a 52 week high of $0.93. The firm has a fifty day simple moving average of $0.93 and a 200-day simple moving average of $0.93.

About China Medical System

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.